Critical Care (journal)
Critical Care is a peer-reviewed medical journal that covers research in the field of intensive care medicine. The journal publishes articles on a broad range of topics related to critical care, including clinical trials, epidemiology, health services and outcomes research, and model development.
History[edit]
The journal was established in 1997. It is published by BioMed Central, a publisher of open access journals. The editor-in-chief is Jean-Louis Vincent, a professor of intensive care at the University of Brussels.
Content[edit]
Critical Care publishes original research, review articles, commentaries, and letters to the editor. The journal covers all aspects of critical care, including anesthesiology, cardiology, surgery, infectious diseases, and neurology. It also publishes articles on the management of severe, life-threatening health problems, such as septic shock, respiratory failure, and traumatic brain injury.
Abstracting and indexing[edit]
The journal is abstracted and indexed in PubMed Central, Scopus, EMBASE, and the Science Citation Index Expanded. According to the Journal Citation Reports, the journal has a 2019 impact factor of 6.959.
Open access[edit]
As an open access journal, all articles published in Critical Care are freely available to read, download, and share. The journal operates under the Creative Commons Attribution License, which allows others to distribute and copy the articles, provided the original work is properly cited.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian